Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus

  • Jia-xin PAN ,
  • Sai-nan ZHU ,
  • Shuang-ling LI ,
  • Dong-xin WANG
Expand
  • 1. Department of Critical Care Medicine, Peking University First Hospital, Beijing 100034, China
    2. Department of Biostatistics, Peking University First Hospital, Beijing 100034, China
    3. Department of Anesthesiology, Peking University First Hospital, Beijing 100034, China

Received date: 2022-06-30

  Online published: 2022-10-14

Abstract

Objective: Critically ill patients with solid tumors complicated with paraneoplastic pemphigus are usually treated in intensive care units (ICU) for perioperative management after surgical treatment. In this study, the clinical characteristics and predictors of long-term prognosis of these critically ill patients were analyzed. Methods: the clinical and laboratory data of 63 patients with solid tumors complicated with paraneoplastic pemphigus admitted to ICU from 2005 to 2020 were retrospectively analyzed, and the survival status of the patients were followed up. Results: Among the 63 patients, 79.4% had Castleman disease as the primary tumor, and 20.6% with other pathological types; 69.8% had severe-extensive skin lesions, and 30.2% had other skin lesions; the patients with bronchiolitis obliterans accounted for 44.4%, and 55.6% were not merged. Postoperative fungal infection occurred in 23.8% of the patients, and 76.2% without fungal infection. The median follow-up time was 95 months, and 25 patients died during the study period. The 1-year, 3-year and 5-year survival rates were 74.6% (95%CI 63.8%-85.4%), 67.4% (95%CI 55.6%-79.2%) and 55.1% (95%CI 47.9%-62.3%), respectively. The log-rank univariate analysis showed that the patients had age>40 years (P=0.042), preoperative weight loss>5 kg (P=0.002), preoperative albumin < 30 g/L (P < 0.001), paraneoplastic pemphigus complicated with bronchiolitis obliterans (P=0.002), and perioperative fungal infection (P < 0.001) had increased mortality. Cox univariate analysis showed that preoperative weight loss >5 kg (P=0.005), preoperative albumin < 30 g/L (P < 0.001), paraneoplastic pemphigus complicated with bronchiolitis obliterans (P=0.009), preoperative bacterial pulmonary infection (P=0.007), prolonged surgical time (P=0.048), postoperative oxygenation index (P=0.012) and low albumin (P=0.010) and hemoglobin concentration (P=0.035) in ICU, acute physiology and chronic health evaluation (APACHE Ⅱ) score (P=0.001); sequential organ failure assessment (SOFA) score (P=0.010), and postoperative fungal infection (P < 0.001) were risk factors for long-term survival. Cox regression model for multivariate analysis showed that preoperative weight loss > 5 kg (HR 4.44; 95%CI 1.47-13.38; P=0.008), and preoperative albumin < 30 g/L (HR 4.38; 95%CI 1.72-11.12; P=0.002), bronchiolitis obliterans (HR 2.69; 95%CI 1.12-6.50; P=0.027), and postoperative fungal infection (HR 4.85; 95%CI 2.01-11.72; P < 0.001) were independent risk factors for postoperative mortality. Conclusion: The 5-year survival rate of critically ill patients undergoing surgery for paraneoplastic pemphigus combined with solid tumors is approximately 55.1%, with preoperative weight loss > 5 kg, albumin < 30 g/L, bronchiolitis obliterans and postoperative fungal infection were associated with an increased risk of near- and long-term postoperative mortality.

Cite this article

Jia-xin PAN , Sai-nan ZHU , Shuang-ling LI , Dong-xin WANG . Factors associated with long-term survival in critically ill patients following surgery for solid tumors complicated with paraneoplastic pemphigus[J]. Journal of Peking University(Health Sciences), 2022 , 54(5) : 981 -990 . DOI: 10.19723/j.issn.1671-167X.2022.05.027

References

1 Anhalt GJ , Kim SC , Stanley JR , et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia[J]. N Engl J Med, 1990, 323 (25): 1729- 1735.
2 Nguyen VT , Ndoye A , Bassler KD , et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus[J]. Arch Dermatol, 2001, 137 (2): 193- 206.
3 Paolino G , Didona D , Magliulo G , et al. Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy[J]. Int J Mol Sci, 2017, 18 (12): 2532.
4 Solimani F , Maglie R , Pollmann R , et al. Thymoma-associated paraneoplastic autoimmune multiorgan syndrome: from pemphigus to lichenoid dermatitis[J]. Front Immunol, 2019, 10, 1413.
5 Jelti L , Cordel N , Gillibert A , et al. Incidence and mortality of pemphigus in France[J]. J Invest Dermatol, 2019, 139 (2): 469- 473.
6 Cao L , Wang F , Du XY , et al. Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies[J]. Sci Rep, 2020, 10 (1): 16357.
7 Tirado-Sanchez A , Bonifaz A . Paraneoplastic pemphigus. A life-threatening autoimmune blistering disease[J]. Actas Dermosifi-liogr, 2017, 108 (10): 902- 910.
8 Kishi T , Nakata J , Yamada T , et al. Fatal progression of bron-chiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus[J]. Ann Hematol, 2022, 101 (2): 453- 455.
9 Tsuchisaka A , Numata S , Teye K , et al. Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients[J]. J Invest Dermatol, 2016, 136 (2): 399- 408.
10 Aguilar PR , Michelson AP , Isakow W . Obliterative bronchiolitis[J]. Transplantation, 2016, 100 (2): 272- 283.
11 Krain RL , Kushner CJ , Tarazi M , et al. Assessing the correlation between disease severity indices and quality of life measurement tools in pemphigus[J]. Front Immunol, 2019, 10, 2571.
12 Czernik A , Camilleri M , Pittelkow MR , et al. Paraneoplastic autoimmune multiorgan syndrome: 20 years after[J]. Int J Dermatol, 2011, 50 (8): 905- 914.
13 Yong AA , Tey HL . Paraneoplastic pemphigus[J]. Australas J Dermatol, 2013, 54 (4): 241- 250.
14 Wang J , Zhu X , Li R , et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China[J]. Arch Dermatol, 2005, 141 (10): 1285- 1293.
15 Leger S , Picard D , Ingen-Housz-Oro S , et al. Prognostic factors of paraneoplastic pemphigus[J]. Arch Dermatol, 2012, 148 (10): 1165.
16 Dong Y , Wang M , Nong L , et al. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor[J]. Br J Haematol, 2015, 169 (6): 834- 842.
17 Ouedraogo E , Gottlieb J , de Masson A , et al. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults[J]. J Am Acad Dermatol, 2019, 80 (6): 1544- 1549.
18 Wang M , Li F , Wang X , et al. Features and risk factors for paraneoplastic autoimmune multiorgan syndrome in 145 Chinese patients[J]. Acta Derm Venereol, 2020, 100 (18): adv00312.
19 Kartan S , Shi VY , Clark AK , et al. Paraneoplastic pemphigus and autoimmune blistering diseases associated with neoplasm: characteristics, diagnosis, associated neoplasms, proposed pathogenesis, treatment[J]. Am J Clin Dermatol, 2017, 18 (1): 105- 126.
Outlines

/